Colgate-Palmolive Company $CL Stock Acquired by International Assets Investment Management LLC

International Assets Investment Management LLC increased its stake in Colgate-Palmolive Company (NYSE:CL) by 171.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 10,000 shares of the company’s stock after purchasing an additional 6,317 shares during the quarter. International Assets Investment Management LLC’s holdings in Colgate-Palmolive were worth $853,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in CL. CHICAGO TRUST Co NA boosted its holdings in Colgate-Palmolive by 39.9% in the 3rd quarter. CHICAGO TRUST Co NA now owns 7,197 shares of the company’s stock worth $614,000 after buying an additional 2,053 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al grew its position in shares of Colgate-Palmolive by 12.2% during the third quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 1,359,738 shares of the company’s stock worth $116,013,000 after purchasing an additional 147,800 shares in the last quarter. Partners Wealth Management LLC bought a new position in Colgate-Palmolive in the 3rd quarter worth approximately $419,000. Soltis Investment Advisors LLC grew its holdings in Colgate-Palmolive by 20.0% during the 3rd quarter. Soltis Investment Advisors LLC now owns 16,140 shares of the company’s stock valued at $1,377,000 after buying an additional 2,691 shares in the last quarter. Finally, Founders Financial Securities LLC raised its position in shares of Colgate-Palmolive by 40.9% during the third quarter. Founders Financial Securities LLC now owns 4,191 shares of the company’s stock valued at $358,000 after buying an additional 1,216 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Key Headlines Impacting Colgate-Palmolive

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Investors have favored Colgate-Palmolive and other Dividend Kings amid political uncertainty, seeking dependable earnings and dividends. The company’s recent quarterly results also showed resilience: earnings and revenue exceeded consensus estimates, and revenue grew year over year. Article: Dividend Kings hitting 52-week highs
• Positive Sentiment: Several firms delivered supportive signals, including price-target increases from Wells Fargo and RBC, a bullish appreciation outlook from Morgan Stanley, and an Outperform reaffirmation from BNP Paribas Exane. Article: Wells Fargo raises price target Article: Morgan Stanley outlook Article: BNP Paribas Exane reaffirms Outperform Article: RBC raises price target
• Positive Sentiment: Commentary also highlights Colgate-Palmolive’s pricing power to help protect earnings and dividends from inflation, as well as improving execution and a potentially attractive valuation. Article: Dividend stocks with pricing power Article: Improving execution and valuation
• Neutral Sentiment: Barclays raised its target but maintained an Equal Weight/Hold stance, indicating limited conviction that the shares will outperform from current levels. Article: Barclays remains a Hold
• Negative Sentiment: JPMorgan lowered its expectations for CL’s share price, a counterpoint to the recent target increases. Article: JPMorgan lowers price expectations

Analyst Ratings Changes

A number of equities analysts recently weighed in on CL shares. Barclays upped their target price on shares of Colgate-Palmolive from $87.00 to $95.00 and gave the stock an “equal weight” rating in a research report on Tuesday. JPMorgan Chase & Co. cut their price objective on Colgate-Palmolive from $104.00 to $102.00 and set an “overweight” rating for the company in a research report on Monday. Evercore boosted their target price on Colgate-Palmolive from $100.00 to $101.00 and gave the stock an “outperform” rating in a research report on Thursday, October 8th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $101.00 price target (up from $99.00) on shares of Colgate-Palmolive in a report on Monday, August 3rd. Finally, Sanford C. Bernstein reaffirmed a “market perform” rating on shares of Colgate-Palmolive in a report on Thursday, August 13th. Thirteen research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $101.22.

Colgate-Palmolive Stock Performance

NYSE CL opened at $98.65 on Thursday. The company has a market cap of $78.42 billion, a P/E ratio of 38.69, a P/E/G ratio of 4.34 and a beta of 0.31. The company has a debt-to-equity ratio of 11.23, a quick ratio of 0.30 and a current ratio of 0.96. The business’s 50 day moving average price is $89.88 and its 200-day moving average price is $89.85. Colgate-Palmolive Company has a fifty-two week low of $75.96 and a fifty-two week high of $99.69.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, October 30th. The company reported $0.97 earnings per share for the quarter, beating analysts’ consensus estimates of $0.93 by $0.04. Colgate-Palmolive had a net margin of 9.65% and a return on equity of 607.88%. The business had revenue of $5.37 billion for the quarter, compared to analysts’ expectations of $5.34 billion. During the same quarter in the previous year, the business posted $0.91 earnings per share. The business’s revenue was up 4.6% compared to the same quarter last year. Sell-side analysts predict that Colgate-Palmolive Company will post 3.91 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th will be given a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a dividend yield of 2.1%. The ex-dividend date is Tuesday, October 20th. Colgate-Palmolive’s payout ratio is 83.14%.

Insider Activity at Colgate-Palmolive

In other news, COO Panagiotis Tsourapas sold 10,000 shares of the stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $92.05, for a total value of $920,500.00. Following the sale, the chief operating officer directly owned 64,901 shares in the company, valued at approximately $5,974,137.05. This represents a 13.35% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.43% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwash, liquid hand soap, body wash, deodorants, household cleaning products and pet food and treats.

The company markets well-known brands such as Colgate, Palmolive, elmex, meridol, Softsoap, Irish Spring, Ajax, Protex and Hill’s Science Diet. Colgate-Palmolive also provides veterinary and nutritional products through Hill’s Pet Nutrition, which serves pet owners and animal health professionals.

Founded in 1806 by William Colgate, the company developed from a soap and candle business into a diversified consumer goods manufacturer.